NCT00070421

Brief Summary

RATIONALE: Using an Internet Web site that enables children with cancer to interact online with classmates, participate in classroom activities, get easy-to-read medical information, and chat with family members, medical staff, and other children with cancer may help children cope with isolation, fear, and decreased self-esteem. PURPOSE: This phase I/II trial is studying the effectiveness of an Internet Web site in providing social support and education to children who are undergoing treatment for cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Apr 2003

Shorter than P25 for phase_1 leukemia

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2003

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 3, 2003

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 7, 2003

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2005

Completed
Last Updated

May 15, 2013

Status Verified

December 1, 2004

First QC Date

October 3, 2003

Last Update Submit

May 14, 2013

Conditions

LeukemiaLymphomaPsychosocial Effects of Cancer and Its TreatmentUnspecified Childhood Solid Tumor, Protocol Specific

Keywords

psychosocial effects of cancer and its treatmentunspecified childhood solid tumor, protocol specificchildhood acute lymphoblastic leukemia in remissionchildhood acute myeloid leukemia in remissionrecurrent childhood acute lymphoblastic leukemiarecurrent childhood acute myeloid leukemiarecurrent childhood large cell lymphomarecurrent childhood lymphoblastic lymphomarecurrent childhood small noncleaved cell lymphomastage I childhood Hodgkin lymphomastage I childhood large cell lymphomastage I childhood lymphoblastic lymphomastage I childhood small noncleaved cell lymphomastage II childhood Hodgkin lymphomastage II childhood large cell lymphomastage II childhood lymphoblastic lymphomastage II childhood small noncleaved cell lymphomastage III childhood Hodgkin lymphomastage III childhood large cell lymphomastage III childhood lymphoblastic lymphomastage III childhood small noncleaved cell lymphomastage IV childhood Hodgkin lymphomastage IV childhood large cell lymphomastage IV childhood lymphoblastic lymphomastage IV childhood small noncleaved cell lymphomarecurrent/refractory childhood Hodgkin lymphoma

Interventions

complementary or alternative medicine procedurePROCEDURE
management of therapy complicationsPROCEDURE
psychosocial assessment and carePROCEDURE

Eligibility Criteria

Age10 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
DISEASE CHARACTERISTICS: * Diagnosis of cancer * Currently receiving treatment for cancer PATIENT CHARACTERISTICS: Age * 10 to 15 Performance status * Active Life expectancy * Not specified Hematopoietic * Not specified Hepatic * Not specified Renal * Not specified Other * Able to read and speak English PRIOR CONCURRENT THERAPY: Biologic therapy * Not specified Chemotherapy * Not specified Endocrine therapy * Not specified Radiotherapy * Not specified Surgery * Not specified

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Leap of Faith Technologies, Incorporated

Crystal Lake, Illinois, 60014, United States

Location

MeSH Terms

Conditions

LeukemiaLymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaDendritic Cell Sarcoma, InterdigitatingBurkitt LymphomaRecurrence

Interventions

Psychiatric Rehabilitation

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System DiseasesLeukemia, LymphoidHistiocytic Disorders, MalignantHistiocytosisEpstein-Barr Virus InfectionsHerpesviridae InfectionsDNA Virus InfectionsVirus DiseasesInfectionsTumor Virus InfectionsLymphoma, B-CellLymphoma, Non-HodgkinDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Barbara Rapchak

    Leap of Faith Technologies

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 1
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

October 3, 2003

First Posted

October 7, 2003

Study Start

April 1, 2003

Study Completion

January 1, 2005

Last Updated

May 15, 2013

Record last verified: 2004-12

Locations

US(1)